CORPORATE RESPONSIBILITY AT RELX, 2021 HIGHLIGHTS
In 2021, RELX continued to build on our strong corporate responsibility (CR) performance during the year, further improving on our key internal metrics and extending the scope of our unique contributions. This article is linked to SDGs 1,3,10,11,12,13 and 16, in line with RELX's areas of expertise.
Elsevier,

Surgical Oncology Clinics of North America, Volume 32, Issue 1, 2023, Pages 221-232

This chapter advances Goals 5 and 10 by discussing the role physicians can play in improving clinical trial enrollment and retention among underrepresented groups.
This Article supports SDGs 3, 5, 10 and 16 by assessing changes in stillbirth rates overall and for Black and White women, finding that there was a substantial racial disparity and suggesting that targeted health and social policies are needed to address this issue.
Elsevier,

Women's Health in Medical Clinics of North America Volume 7, Issue 2, p. 385-395, March 2023

This content advances goals 5 and 10 by covering the risk factors, consquences, treatments, and optimal support and resources for victims of intimate partner violence.
Dismantling racism in health care demands that medical education promote racial justice throughout all stages of medical training. The development of any anti-racism curriculum in medicine requires the ability to identify racial bias in practices we have not previously recognized as explicitly racist or unjust.
This falls along the themes of public access (or lack thereof) to physicians has many different consequences to good health and well-being especially with cancer care.
This paper shows that although climate policies can sometimes slow the pace of economic growth, in the long term the benefits of avoided climate change impacts will overweight policy costs
Elsevier,

The Lancet Regional Health - Americas, Volume 17, January 2023, 100408

This viewpoint supports SDGs 3, 5, 10 and 16, focusing on the drivers of Black maternal mortality and advocating the collection of disaggregated data to support improvements in Black maternal health.
Experts in the field, along with patient representatives from the Sarcoma Patient Advocacy Global Network (SPAGN), met at an international consensus meeting in 2022 to define best clinical practice of tenosynovial giant cell tumour (TGCT). Although usually not life-threatening, TGCT may cause chronic pain and adversely impact function and quality of life. A global effort is needed to make active systemic treatments available to TGCT patients worldwide and avoid discrimination.
This Article supports SDGs 3 and 10 by showing that, globally, Black women are at higher risk of adverse perinatal outcomes of neonatal death, stillbirth, preterm birth, and small-for-gestational-age babies than White women, even after adjusting for maternal characteristics. Moreover, these racial disparities in perinatal outcomes were consistently observed across all geographical regions.

Pages